Plasma Therapeutics Market Size, Share, and Outlook, H2-2025 Report- By Product (Immunoglobulin, Albumin, Blood Factors, Others) and Companies, 2021-2032
Description
Plasma Therapeutics Market Outlook
The global Plasma Therapeutics Market Size is valued at $34.1 Billion in 2025 and is forecast to reach $52.3 Billion in 2032 at a CAGR of 6.3%.
The Plasma Therapeutics Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Plasma Therapeutics Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product (Immunoglobulin, Albumin, Blood Factors, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Plasma Therapeutics Market Insights, 2025
The plasma therapeutics market is advancing with the development of innovative plasma-derived products and recombinant alternatives targeting immunodeficiencies, coagulation disorders, and neurological conditions. Recent breakthroughs include enhanced fractionation techniques yielding higher purity and potency products like immunoglobulins, clotting factors, and albumin. The emergence of recombinant and synthetic plasma proteins addresses supply constraints and reduces infection risks. The COVID-19 pandemic spotlighted convalescent plasma therapy’s potential, spurring research and regulatory pathways for emergency use. Manufacturing automation and pathogen reduction technologies improve scalability and safety. Market growth is also driven by increased diagnosis of plasma protein deficiencies and expanding indications. Regulatory frameworks focus on rigorous quality control and traceability across the plasma supply chain. Collaborative efforts between plasma centers, manufacturers, and healthcare providers optimize collection and distribution networks.
Five Trends Shaping the Global Plasma Therapeutics Market in 2025 and Beyond
The global Plasma Therapeutics Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Plasma Therapeutics Industry?
The Plasma Therapeutics Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Plasma Therapeutics Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Plasma Therapeutics Market Segment Insights
The Plasma Therapeutics Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product (Immunoglobulin, Albumin, Blood Factors, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Plasma Therapeutics Industry Value Chain
The chapter identifies potential companies and their operations across the global Plasma Therapeutics Industry ecosystem. It assists decision-makers in evaluating global Plasma Therapeutics Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Plasma Therapeutics Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Plasma Therapeutics Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Plasma Therapeutics Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Plasma Therapeutics Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Plasma Therapeutics Market.
Europe Plasma Therapeutics Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Plasma Therapeutics Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Plasma Therapeutics Industry competitiveness. The report analyses the key Plasma Therapeutics Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Plasma Therapeutics Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Plasma Therapeutics Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Plasma Therapeutics Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Plasma Therapeutics Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Plasma Therapeutics Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Plasma Therapeutics Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes ADMA Biologics Inc, Bio Products Laboratory Ltd, BIOPHARMA PLASMA, CSL Ltd, Emergent BioSolutions Inc, Evolve Biologics Inc, Grifols SA, Kamada Ltd, Kedrion Spa, Octapharma AG, Pfizer Inc, Prothya Biosolutions Netherlands BV, SK Discovery Co. Ltd, Takeda Pharmaceutical Co. Ltd. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Plasma Therapeutics Market Scope
Leading Segments
By Product
Immunoglobulin
Albumin
Blood Factors
Others
Leading Companies
ADMA Biologics Inc
Bio Products Laboratory Ltd
BIOPHARMA PLASMA
CSL Ltd
Emergent BioSolutions Inc
Evolve Biologics Inc
Grifols SA
Kamada Ltd
Kedrion Spa
Octapharma AG
Pfizer Inc
Prothya Biosolutions Netherlands BV
SK Discovery Co. Ltd
Takeda Pharmaceutical Co. Ltd
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Plasma Therapeutics Market Size is valued at $34.1 Billion in 2025 and is forecast to reach $52.3 Billion in 2032 at a CAGR of 6.3%.
The Plasma Therapeutics Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Plasma Therapeutics Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product (Immunoglobulin, Albumin, Blood Factors, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Plasma Therapeutics Market Insights, 2025
The plasma therapeutics market is advancing with the development of innovative plasma-derived products and recombinant alternatives targeting immunodeficiencies, coagulation disorders, and neurological conditions. Recent breakthroughs include enhanced fractionation techniques yielding higher purity and potency products like immunoglobulins, clotting factors, and albumin. The emergence of recombinant and synthetic plasma proteins addresses supply constraints and reduces infection risks. The COVID-19 pandemic spotlighted convalescent plasma therapy’s potential, spurring research and regulatory pathways for emergency use. Manufacturing automation and pathogen reduction technologies improve scalability and safety. Market growth is also driven by increased diagnosis of plasma protein deficiencies and expanding indications. Regulatory frameworks focus on rigorous quality control and traceability across the plasma supply chain. Collaborative efforts between plasma centers, manufacturers, and healthcare providers optimize collection and distribution networks.
Five Trends Shaping the Global Plasma Therapeutics Market in 2025 and Beyond
The global Plasma Therapeutics Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Plasma Therapeutics Industry?
The Plasma Therapeutics Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Plasma Therapeutics Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Plasma Therapeutics Market Segment Insights
The Plasma Therapeutics Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product (Immunoglobulin, Albumin, Blood Factors, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Plasma Therapeutics Industry Value Chain
The chapter identifies potential companies and their operations across the global Plasma Therapeutics Industry ecosystem. It assists decision-makers in evaluating global Plasma Therapeutics Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Plasma Therapeutics Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Plasma Therapeutics Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Plasma Therapeutics Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Plasma Therapeutics Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Plasma Therapeutics Market.
Europe Plasma Therapeutics Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Plasma Therapeutics Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Plasma Therapeutics Industry competitiveness. The report analyses the key Plasma Therapeutics Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Plasma Therapeutics Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Plasma Therapeutics Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Plasma Therapeutics Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Plasma Therapeutics Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Plasma Therapeutics Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Plasma Therapeutics Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes ADMA Biologics Inc, Bio Products Laboratory Ltd, BIOPHARMA PLASMA, CSL Ltd, Emergent BioSolutions Inc, Evolve Biologics Inc, Grifols SA, Kamada Ltd, Kedrion Spa, Octapharma AG, Pfizer Inc, Prothya Biosolutions Netherlands BV, SK Discovery Co. Ltd, Takeda Pharmaceutical Co. Ltd. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Plasma Therapeutics Market Scope
Leading Segments
By Product
Immunoglobulin
Albumin
Blood Factors
Others
Leading Companies
ADMA Biologics Inc
Bio Products Laboratory Ltd
BIOPHARMA PLASMA
CSL Ltd
Emergent BioSolutions Inc
Evolve Biologics Inc
Grifols SA
Kamada Ltd
Kedrion Spa
Octapharma AG
Pfizer Inc
Prothya Biosolutions Netherlands BV
SK Discovery Co. Ltd
Takeda Pharmaceutical Co. Ltd
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
196 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Plasma Therapeutics Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Plasma Therapeutics Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Plasma Therapeutics Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Plasma Therapeutics Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Plasma Therapeutics Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Product
- Immunoglobulin
- Albumin
- Blood Factors
- Others
- 6. Global Plasma Therapeutics Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Plasma Therapeutics Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Plasma Therapeutics Market Trends and Growth Opportunities
- 6.2.1 North America Plasma Therapeutics Market Outlook by Type
- 6.2.2 North America Plasma Therapeutics Market Outlook by Application
- 6.3 North America Plasma Therapeutics Market Outlook by Country
- 6.3.1 The US Plasma Therapeutics Market Outlook, 2021- 2032
- 6.3.2 Canada Plasma Therapeutics Market Outlook, 2021- 2032
- 6.3.3 Mexico Plasma Therapeutics Market Outlook, 2021- 2032
- 7. Europe Plasma Therapeutics Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Plasma Therapeutics Market Trends and Growth Opportunities
- 7.2.1 Europe Plasma Therapeutics Market Outlook by Type
- 7.2.2 Europe Plasma Therapeutics Market Outlook by Application
- 7.3 Europe Plasma Therapeutics Market Outlook by Country
- 7.3.2 Germany Plasma Therapeutics Market Outlook, 2021- 2032
- 7.3.3 France Plasma Therapeutics Market Outlook, 2021- 2032
- 7.3.4 The UK Plasma Therapeutics Market Outlook, 2021- 2032
- 7.3.5 Spain Plasma Therapeutics Market Outlook, 2021- 2032
- 7.3.6 Italy Plasma Therapeutics Market Outlook, 2021- 2032
- 7.3.7 Russia Plasma Therapeutics Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Plasma Therapeutics Market Outlook, 2021- 2032
- 8. Asia Pacific Plasma Therapeutics Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Plasma Therapeutics Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Plasma Therapeutics Market Outlook by Type
- 8.2.2 Asia Pacific Plasma Therapeutics Market Outlook by Application
- 8.3 Asia Pacific Plasma Therapeutics Market Outlook by Country
- 8.3.1 China Plasma Therapeutics Market Outlook, 2021- 2032
- 8.3.2 India Plasma Therapeutics Market Outlook, 2021- 2032
- 8.3.3 Japan Plasma Therapeutics Market Outlook, 2021- 2032
- 8.3.4 South Korea Plasma Therapeutics Market Outlook, 2021- 2032
- 8.3.5 Australia Plasma Therapeutics Market Outlook, 2021- 2032
- 8.3.6 South East Asia Plasma Therapeutics Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Plasma Therapeutics Market Outlook, 2021- 2032
- 9. South America Plasma Therapeutics Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Plasma Therapeutics Market Trends and Growth Opportunities
- 9.2.1 South America Plasma Therapeutics Market Outlook by Type
- 9.2.2 South America Plasma Therapeutics Market Outlook by Application
- 9.3 South America Plasma Therapeutics Market Outlook by Country
- 9.3.1 Brazil Plasma Therapeutics Market Outlook, 2021- 2032
- 9.3.2 Argentina Plasma Therapeutics Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Plasma Therapeutics Market Outlook, 2021- 2032
- 10. Middle East and Africa Plasma Therapeutics Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Plasma Therapeutics Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Plasma Therapeutics Market Outlook by Type
- 10.2.2 Middle East and Africa Plasma Therapeutics Market Outlook by Application
- 10.3 Middle East and Africa Plasma Therapeutics Market Outlook by Country
- 10.3.1 Saudi Arabia Plasma Therapeutics Market Outlook, 2021- 2032
- 10.3.2 The UAE Plasma Therapeutics Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Plasma Therapeutics Market Outlook, 2021- 2032
- 10.3.4 South Africa Plasma Therapeutics Market Outlook, 2021- 2032
- 10.3.5 Egypt Plasma Therapeutics Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Plasma Therapeutics Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- ADMA Biologics Inc
- Bio Products Laboratory Ltd
- BIOPHARMA PLASMA
- CSL Ltd
- Emergent BioSolutions Inc
- Evolve Biologics Inc
- Grifols SA
- Kamada Ltd
- Kedrion Spa
- Octapharma AG
- Pfizer Inc
- Prothya Biosolutions Netherlands BV
- SK Discovery Co. Ltd
- Takeda Pharmaceutical Co. Ltd
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
